Sartorius Stedim Biotech

News Details

FR Regulatory | 3 November 2025 11:32

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL

Sartorius Stedim Biotech SA

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL

03-Nov-2025 / 11:32 CET/CEST

Dissemination of a French Regulatory News, transmitted by EQS Group.

The issuer is solely responsible for the content of this announcement.

Sartorius Stedim Biotech S.A. – 13400 Aubagne, France

DECLARATION RELATIVE TO

THE NUMBER OF SHARES AND VOTING RIGHTS

MAKING UP THE ISSUED CAPITAL

Article L 233-8-II of the Code of commerce

and article 223-6 of the general regulations of the AMF

Designation of issuer

SARTORIUS STEDIM BIOTECH SA

CS 91051

Z. I. Les Paluds

Avenue de Jouques

13400 Aubagne


Date of information	Total number of shares making up the issued capital	Total number of theoretical voting rights including treasury shares	Total number of net voting rights
October 31, 2025	97,330,405	165,543,716	165,512,326

Regulatory filing PDF file


- - -
Language:	English
Company:	Sartorius Stedim Biotech SA
	Avenue de Jouques
	13781 Aubagne
	France
Phone:	+33 44 284 5600
E-mail:	[email protected]
Internet:	www.sartorius.com
ISIN:	FR0013154002
Euronext Ticker:	DIM
AMF Category:	Total number of voting rights and share capital / Information on the total number of voting rights and the number of shares making up the share capital
EQS News ID:	2222718



End of Announcement	EQS News Service

2222718 03-Nov-2025 CET/CEST

AI Terminal